General Atlantic

General Atlantic is one of the largest growth equity firms in the world, and its healthcare engagement is part of a broader strategy of backing high-growth, technology-enabled companies across sectors and geographies. From its New York base, the firm provides capital and strategic support to digital health and healthcare software companies that have already established product-market fit and are scaling toward category leadership. For founders, this is late-stage capital with a global apparatus rather than an early-stage venture check.

The thesis is digital health and healthcare software, with a working interest in companies whose business model is fundamentally a software or technology-enabled platform rather than a services-only operation. AI focus is real and reflects the firm’s broader move into AI-native enterprise companies across its portfolio. Founders without proven scale or a credible path to category leadership are typically a less natural fit; founders with both should expect a serious specialist process within the firm’s healthcare team.

Checks fall in the twenty-five million dollar plus range at the growth stage, which positions General Atlantic as a significant minority investor in companies with substantial existing revenue. Geography is global, with the firm operating from offices across multiple continents and supporting companies in their international expansion. New York functions as a coordinating hub rather than a geographic constraint.

The firm is structured around a global partnership with sector teams that bring specialist expertise, and its healthcare practice draws on operating advisors and portfolio relationships that span the broader sector. That structure is part of what founders are evaluating when they take a General Atlantic check.

The approach is growth-stage and globally oriented. The firm is most useful on questions of international expansion, the build-out of executive teams capable of operating at substantially larger scale, the choice of strategic and operational partnerships that accelerate category leadership, and the long-term work of preparing a company for either a public-market listing or a strategic transaction. Process is rigorous and reflects the firm’s growth-equity discipline: detailed commercial diligence, structured term negotiations, and an explicit operating plan with clear milestones. Follow-on capital is part of the firm’s strategy and consistent with its growth focus. The trade-offs for founders are the usual late-stage growth concerns: governance shifts, a heightened focus on execution discipline, and an explicit exit horizon. For digital health and healthcare software founders with proven scale and a global ambition, the proposition is specific and well-resourced.